PDEX — Stock Film
STOCK FILMSCENE 1/11PDEX · $62.81
Stock Expert AI presents
PDEX
Pro-Dex, Inc
~5 min film100% real numbersplain English
WHAT DOES THIS COMPANY DO?
Pro-Dex, Inc. What it actually does.

Design and manufacture powered surgical instruments for medical device OEMs. Offer a range of autoclavable, battery-powered, and electric surgical drivers and shavers. Now — the numbers.

on the stock market since 1986
201 employees
$200.5M market value
Revenue last year:
$77.5M
The net profit left over:
$13.7M
Out of every $100 in sales, $18 stays as net profit.
THE SLICE THAT TURNS INTO PROFIT: 18%

This is an established company with proven profits.

THE SALES TREND
Sales are growing, year after year.

Average growth of 17% a year over the last 4 years. Every year shown ended in profit.

$42M
2022
2023
2024
2025
$77.5M
2026
Cash on hand:
$9.3M
Total debt:
$18.1M
The debt outweighs the cash.

The gap is $8.8M. In times of high interest rates, a gap like that can squeeze a company.

THE PRICE TAG
MARKET VALUE / ANNUAL PROFIT
14.7×

The market pays 14.7× for every dollar of annual profit — around what a business like this usually costs.

Against companies in its own sector, it looks cheaper than 64% of them.

No analyst target is on record for this company.

INSIDE THE REPORT CARD

We compared this company with its own sector across five subjects.

A score of 50 means class average.

BUSINESS QUALITY
90
very strong

Profit power and business quality lead the class.

FINANCIAL STRENGTH
86
very strong

A solid grade overall — yet the debt outweighs the cash. The strength here comes from earnings power.

VALUATION
64
average

The price isn’t cheap next to earnings — that’s why this grade sits in the middle.

GROWTH
97
very strong

Sales are growing strongly for its sector.

PRICE MOMENTUM
73
strong

Clearly above the class average — a step short of the very top.

No real weak spot in any of the five subjects — a balanced report card.

THE FIVE-YEAR JOURNEY
Trading below its recent peak.

The stock trades below its recent peak — about 14% off the top. A pullback, not a collapse.

1
THE BRIGHT SIDE · 1/3
A fat profit margin

The net profit margin is 18% — that slice of every sale is the company’s cushion in hard quarters.

2
THE BRIGHT SIDE · 2/3
Sales keep climbing

Over the last 4 years, sales grew about 17% a year on average.

3
THE BRIGHT SIDE · 3/3
Delivers on expectations

It met or beat analyst expectations in 7 of the last 8 quarters — consistency is a promise kept.

1
THE RISKS · 1/1
Executives lean toward selling

Over the last 12 months, executives reported 23 sells against just 4 buys. Not an alarm bell by itself, but a number worth watching.

FINALE · THE GRADE
A+
81 / 100 · MoonshotScore

On our five-subject report card, PDEX sits near the top of the class. A high grade doesn’t mean “guaranteed win” — it means “the evidence looks strong for now.”

The takeaway: PDEX is an established business that has proven its profits for years. The real debate isn’t the quality of the business — it’s what that quality should cost.

What would you like to do next?
Open the stock page →

Not covered, because the filings we hold do not carry it: the revenue breakdown.

This was a film — not investment advice.
Data: FMP & company filings
Sep 11, 2026 · stockexpertai.com · Stock Film